Mechanisms of nucleoporin-mediated gene regulation

NIH RePORTER · NIH · R01 · $408,913 · view on reporter.nih.gov ↗

Abstract

Project Summary/Abstract The genome is housed within the nucleus, where transcription is regulated by architectural features that direct DNA packaging and epigenetic modifications. How genome organization and modification are controlled to allow proper gene expression and normal organismal development is an ongoing area of inquiry. Recent discoveries highlight the important role of the nuclear pore complex (NPC), which regulates transport of biomolecules between the cytosol and nucleus, in transcription control. The NPC protein Nup98 has the ability to move on and off the NPC structure to associate with specific sites in the genome inside the nucleus. Research has shown that this interaction promotes gene activation in developing tissues and that its disruption causes leukemia, hinting at the functional importance of Nup98-directed gene activation for normal development. A recently identified variant of another nucleoporin protein termed sPom121 (“short Pom121), which has completely lost the ability to associate with the NPC but interacts with Nup98 and other nucleoporins within the nucleus to regulate genes. sPom121 recruits additional nucleoporin proteins, and likely other unknown proteins, to structures within the nucleoplasm that we refer to as chromatin-associated nucleoporin complexes, or CNCs. Building on recent findings on the overlapping functions of Nup98 and sPom121 to dissect the roles of CNCs in gene regulation in mammals. Specifically, it will be determined what chromatin modifying enzymes Nup98 associates with to mediate gene activation, and determine how those interactions and gene targets are de-regulated in leukemia. sPom121 specifically marks intranuclear sites of genome regulation (CNCs) but does not associate with the NPC to identify nucleoporin-associated proteins that function in gene regulation. Studies will provide new information about Nup98 as a transcription regulator in hematopoietic cells and have the potential to establish CNCs as a novel feature of gene regulation and genome organization.

Key facts

NIH application ID
9834953
Project number
5R01GM126829-03
Recipient
SALK INSTITUTE FOR BIOLOGICAL STUDIES
Principal Investigator
Martin W Hetzer
Activity code
R01
Funding institute
NIH
Fiscal year
2020
Award amount
$408,913
Award type
5
Project period
2018-01-01 → 2021-11-30